Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium - PubMed (original) (raw)
Multicenter Study
doi: 10.1158/1055-9965.EPI-08-0347. Epub 2009 Feb 3.
Paul Brennan, Shu-Chun Chuang, Stefania Boccia, Xavier Castellsague, Chu Chen, Maria Paula Curado, Luigino Dal Maso, Alexander W Daudt, Eleonora Fabianova, Leticia Fernandez, Victor Wünsch-Filho, Silvia Franceschi, Richard B Hayes, Rolando Herrero, Karl Kelsey, Sergio Koifman, Carlo La Vecchia, Philip Lazarus, Fabio Levi, Juan J Lence, Dana Mates, Elena Matos, Ana Menezes, Michael D McClean, Joshua Muscat, Jose Eluf-Neto, Andrew F Olshan, Mark Purdue, Peter Rudnai, Stephen M Schwartz, Elaine Smith, Erich M Sturgis, Neonilia Szeszenia-Dabrowska, Renato Talamini, Qingyi Wei, Deborah M Winn, Oxana Shangina, Agnieszka Pilarska, Zuo-Feng Zhang, Gilles Ferro, Julien Berthiller, Paolo Boffetta
Affiliations
- PMID: 19190158
- PMCID: PMC3051410
- DOI: 10.1158/1055-9965.EPI-08-0347
Multicenter Study
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium
Mia Hashibe et al. Cancer Epidemiol Biomarkers Prev. 2009 Feb.
Abstract
Background: The magnitude of risk conferred by the interaction between tobacco and alcohol use on the risk of head and neck cancers is not clear because studies have used various methods to quantify the excess head and neck cancer burden.
Methods: We analyzed individual-level pooled data from 17 European and American case-control studies (11,221 cases and 16,168 controls) participating in the International Head and Neck Cancer Epidemiology consortium. We estimated the multiplicative interaction parameter (psi) and population attributable risks (PAR).
Results: A greater than multiplicative joint effect between ever tobacco and alcohol use was observed for head and neck cancer risk (psi = 2.15; 95% confidence interval, 1.53-3.04). The PAR for tobacco or alcohol was 72% (95% confidence interval, 61-79%) for head and neck cancer, of which 4% was due to alcohol alone, 33% was due to tobacco alone, and 35% was due to tobacco and alcohol combined. The total PAR differed by subsite (64% for oral cavity cancer, 72% for pharyngeal cancer, 89% for laryngeal cancer), by sex (74% for men, 57% for women), by age (33% for cases <45 years, 73% for cases >60 years), and by region (84% in Europe, 51% in North America, 83% in Latin America).
Conclusions: Our results confirm that the joint effect between tobacco and alcohol use is greater than multiplicative on head and neck cancer risk. However, a substantial proportion of head and neck cancers cannot be attributed to tobacco or alcohol use, particularly for oral cavity cancer and for head and neck cancer among women and among young-onset cases.
Figures
Figure 1
Multiplicative interaction parameters (ψ) for tobacco (cigarette, cigar, pipe, snuff, chewing tobacco) and alcohol study and combined, using INHANCE pooled data version 1.1. ORs used to calculate ψ were adjusted for age, sex, race/ethnicity, education level.
References
- Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, Version 2.0. IARC Cancer Base No. 5. Lyon, France: IARC Press; 2004.
- Baron AE, Franceschi S, Barra S, Talamini R, La Vecchia C. A comparison of the joint effects of alcohol and smoking on the risk of cancer across sites in the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev. 1993;2:519–23. - PubMed
- Benhamou S, Tuimala J, Bouchardy C, Dayer P, Sarasin A, Hirvonen A. DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract. Int J Cancer. 2004;112(5):901–4. - PubMed
- Boccia S, Cadoni G, Sayed-Tabatabaei FA, Volante M, Arzani D, De Lauretis A, Cattel C, Almadori G, van Duijn CM, Paludetti G, Ricciardi G. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol. 2007;134:93–100. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 DE13110/DE/NIDCR NIH HHS/United States
- T32 CA09142/CA/NCI NIH HHS/United States
- P30 ES010126/ES/NIEHS NIH HHS/United States
- P01 CA068384/CA/NCI NIH HHS/United States
- R01 DA011386/DA/NIDA NIH HHS/United States
- R03 TW001500/TW/FIC NIH HHS/United States
- R01 CA048896/CA/NCI NIH HHS/United States
- R01 ES11740/ES/NIEHS NIH HHS/United States
- R01 CA61188/CA/NCI NIH HHS/United States
- R01 CA100679/CA/NCI NIH HHS/United States
- R03 CA113157/CA/NCI NIH HHS/United States
- R24 HD050924/HD/NICHD NIH HHS/United States
- R01 CA100264/CA/NCI NIH HHS/United States
- R01 DE11979/DE/NIDCR NIH HHS/United States
- U01 CA96134/CA/NCI NIH HHS/United States
- R03 CA113157-02/CA/NCI NIH HHS/United States
- R01 ES011740/ES/NIEHS NIH HHS/United States
- R01 DE012609/DE/NIDCR NIH HHS/United States
- R01 CA078609/CA/NCI NIH HHS/United States
- K07 CA104231/CA/NCI NIH HHS/United States
- P50 CA90388/CA/NCI NIH HHS/United States
- T32 CA009142/CA/NCI NIH HHS/United States
- U01 CA096134/CA/NCI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- R01 DA11386/DA/NIDA NIH HHS/United States
- R03 CA077954/CA/NCI NIH HHS/United States
- R21 ES011667/ES/NIEHS NIH HHS/United States
- TW01500/TW/FIC NIH HHS/United States
- R03 CA113157-01/CA/NCI NIH HHS/United States
- R03 CA77954/CA/NCI NIH HHS/United States
- P50 CA090388/CA/NCI NIH HHS/United States
- R01 DE013110/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical